AVXL insider buying – Anavex Life Sciences Corp.
4 insider purchases since 2016 worth $58,609 by 2 different insiders. Last 12 months: 0 purchases, $0. Most recent filing: 2024-06-17.
Mid company Public float $708M (latest 10-K, SEC).
Same time range as the chart above - each mark sits under the week of the trade. Circles = purchases (height = price paid, size = amount), red triangles = open-market sales of $50k+. Prices as reported, not adjusted for later stock splits. 2 older purchases (before the 5-year window) are listed in the table below.
Purchases are open-market buys (SEC Form 4, code "P") - insiders paying with their own money. Sales are open-market sales (code "S") of $50,000 or more; many sales are pre-planned (Rule 10b5-1) or made for taxes and diversification. Each row links to the original filing.
Bought, sold, still holding?
| Insider | Bought | First / last buy | Sold since 2016 | Holds now* | Status |
|---|---|---|---|---|---|
| Donhauser Peter D.O. Director | $36,009 3× · 5,000 sh | 2021-02-19 2024-06-14 | – | 5,000 shares as of 2024-06-17 | Holds - never sold |
| Thomas Steffen Director | $22,600 1× · 5,000 sh | 2024-05-15 2024-05-15 | – | 55,000 shares as of 2025-06-09 | Holds - never sold |
* Shares held after the insider's most recent SEC filing for this company (all share classes, direct and indirect). If an insider stops filing, later changes are not known.
Insider buying and selling by year
| Year | Purchases | Bought | Buyers | Sales | Sold |
|---|---|---|---|---|---|
| 2024 | 2 | $32,919 | 2 | 1 | $374,972 |
| 2023 | 0 | – | – | 1 | $2.1M |
| 2022 | 0 | – | – | 1 | $453,000 |
| 2021 | 2 | $25,690 | 1 | 4 | $9.3M |
Insider purchases
| Filed | Insider | Role | Shares | Avg price | Value | Holdings | Filing |
|---|---|---|---|---|---|---|---|
| 2024-06-17 | Donhauser Peter D.O. | Director | 2,835 | $3.64 | $10,319 | +130.9% | SEC |
| 2024-05-17 | Thomas Steffen | Director | 5,000 | $4.52 | $22,600 | SEC | |
| 2021-05-19 | Donhauser Peter D.O. | Director | 1,000 | $10.93 | $10,930 | +85.8% | SEC |
| 2021-02-23 | Donhauser Peter D.O. | Director | 1,165 | $12.67 | $14,760 | SEC |
Insider sales
| Filed | Insider | Role | Shares | Avg price | Value | Type | Filing |
|---|---|---|---|---|---|---|---|
| 2024-04-01 | MISSLING CHRISTOPHER U | CEO | 73,380 | $5.11 | $374,972 | Sale | SEC |
| 2023-06-30 | MISSLING CHRISTOPHER U | CEO | 268,000 | $7.98 | $2.1M | Sale | SEC |
| 2022-05-27 | Skarpelos Athanasios | Director | 50,000 | $9.06 | $453,000 | Sale | SEC |
| 2021-07-01 | MISSLING CHRISTOPHER U | CEO | 51,620 | $26.00 | $1.3M | Sale | SEC |
| 2021-07-01 | Boenisch Sandra | Officer | 166,696 | $26.53 | $4.4M | Sale | SEC |
| 2021-05-25 | FAVUS ELLIOT | Director | 145,000 | $11.70 | $1.7M | Sale | SEC |
| 2021-02-26 | FAVUS ELLIOT | Director | 145,500 | $12.66 | $1.8M | Sale | SEC |
Recent company events (SEC 8-K)
- 2026-11-03 - Executive or director change (SEC)
Compiled automatically from public SEC filings. Not investment advice. Get every new insider purchase in the daily report.
Get every new insider purchase the day it's filed
Daily report with all SEC insider buys, cluster buys, company events and the crypto money-flow radar.
Get started free